Clostridioides difficile surface layer protein A (SlpA)

Clostridioides difficile surface layer protein A (SlpA) is the primary constituent of the paracrystalline S-layer that coats the exterior of the bacterium. It is post-translationally cleaved into two subunits: a low molecular weight (LMW) protein and a high molecular weight (HMW) protein, which together form a complex essential for bacterial structural integrity and host cell attachment. As a major virulence factor, SlpA mediates the initial adhesion of C. difficile to the intestinal epithelium, a critical step for colonization and subsequent toxin-mediated tissue damage. In drug development, SlpA is a prominent target for prophylactic vaccines and passive immunotherapy. By targeting these surface antigens, therapeutic agents aim to prevent the establishment of the bacteria in the gut, offering a strategy to reduce recurrence rates which are a major challenge in C. difficile infections. Research focuses on overcoming the high degree of antigenic variation in SlpA across different ribotypes to develop broad-spectrum protection against hypervirulent strains.

Other names

Surface layer protein AS-layer proteinC. difficile surface antigenSlpA precursorLow molecular weight S-layer proteinHigh molecular weight S-layer protein

Vaccines targeting SlpA induce neutralizing antibodies that block bacterial adhesion to the intestinal epithelium and facilitate opsonophagocytosis, thereby preventing colonization and reducing the severity of infection. Monoclonal antibodies bind to the surface layer to inhibit the initial stages of the C. difficile infection cycle.